CN101037475A - 一种嵌合受体及其制备方法和用途 - Google Patents
一种嵌合受体及其制备方法和用途 Download PDFInfo
- Publication number
- CN101037475A CN101037475A CN 200610024703 CN200610024703A CN101037475A CN 101037475 A CN101037475 A CN 101037475A CN 200610024703 CN200610024703 CN 200610024703 CN 200610024703 A CN200610024703 A CN 200610024703A CN 101037475 A CN101037475 A CN 101037475A
- Authority
- CN
- China
- Prior art keywords
- cell
- gly
- leu
- tumour
- cars
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006100247033A CN101037475B (zh) | 2006-03-15 | 2006-03-15 | 一种嵌合受体及其制备方法和用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006100247033A CN101037475B (zh) | 2006-03-15 | 2006-03-15 | 一种嵌合受体及其制备方法和用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101037475A true CN101037475A (zh) | 2007-09-19 |
CN101037475B CN101037475B (zh) | 2012-08-15 |
Family
ID=38888673
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006100247033A Expired - Fee Related CN101037475B (zh) | 2006-03-15 | 2006-03-15 | 一种嵌合受体及其制备方法和用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101037475B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140288280A1 (en) * | 2010-06-08 | 2014-09-25 | Genentech, Inc. | Cysteine engineered antibodies and conjugates |
CN104072616A (zh) * | 2013-03-29 | 2014-10-01 | 上海中信国健药业股份有限公司 | 一种嵌合受体及其制备方法和用途 |
US10077318B2 (en) | 2014-09-12 | 2018-09-18 | Genentech, Inc. | Cysteine engineered antibodies and conjugates |
CN112218653A (zh) * | 2018-06-13 | 2021-01-12 | 哥莫阿波单克隆有限责任公司 | 用于靶向不同的多种抗原的表达反向通用嵌合抗原受体的免疫细胞及其制备方法和用于治疗癌症、感染和自身免疫性病症的用途 |
WO2022127889A1 (zh) * | 2020-12-18 | 2022-06-23 | 江苏先声药业有限公司 | Her2抗体及其应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10156482A1 (de) * | 2001-11-12 | 2003-05-28 | Gundram Jung | Bispezifisches Antikörper-Molekül |
-
2006
- 2006-03-15 CN CN2006100247033A patent/CN101037475B/zh not_active Expired - Fee Related
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140288280A1 (en) * | 2010-06-08 | 2014-09-25 | Genentech, Inc. | Cysteine engineered antibodies and conjugates |
AU2016256788B2 (en) * | 2010-06-08 | 2019-01-03 | Genentech, Inc. | Cysteine engineered antibodies and conjugates |
US10604557B2 (en) | 2010-06-08 | 2020-03-31 | Genentech, Inc. | Cysteine engineered antibodies and conjugates |
US11873330B2 (en) | 2010-06-08 | 2024-01-16 | Genentech, Inc. | Cysteine engineered antibodies and conjugates |
CN104072616A (zh) * | 2013-03-29 | 2014-10-01 | 上海中信国健药业股份有限公司 | 一种嵌合受体及其制备方法和用途 |
US10077318B2 (en) | 2014-09-12 | 2018-09-18 | Genentech, Inc. | Cysteine engineered antibodies and conjugates |
CN112218653A (zh) * | 2018-06-13 | 2021-01-12 | 哥莫阿波单克隆有限责任公司 | 用于靶向不同的多种抗原的表达反向通用嵌合抗原受体的免疫细胞及其制备方法和用于治疗癌症、感染和自身免疫性病症的用途 |
WO2022127889A1 (zh) * | 2020-12-18 | 2022-06-23 | 江苏先声药业有限公司 | Her2抗体及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN101037475B (zh) | 2012-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1294148C (zh) | 环状单链三特异抗体 | |
CN1317301C (zh) | Il-2-和il-15-介导的t细胞应答的调节 | |
CN1835977A (zh) | Cd20-结合多肽组合物 | |
CN1898262A (zh) | Il-7融合蛋白 | |
CN100349920C (zh) | 神经节苷脂相关的重组抗体及其在制备肿瘤的诊断和治疗的药物中的应用 | |
CN1374871A (zh) | 增强蛋白和肽抗原免疫原性的Fc融合蛋白 | |
CN106573969A (zh) | 药物相关的转基因表达 | |
CN1438894A (zh) | 通过阻断淋巴细胞信号和阻断lfa-1介导的粘附作用调节细胞介导的免疫应答的方法 | |
CN1192779A (zh) | 人b7.1和/或b7.2特异的猴源单克隆抗体灵长动物化形式,药用组合物 | |
CN1155904A (zh) | Lag-3蛋白的可溶性多肽组分;生产方法、治疗组合物、抗独特型抗体 | |
CN1518458A (zh) | 移植物排斥反应抑制剂 | |
CN1313903A (zh) | 用于变态反应的预防和/或治疗的化合物和方法 | |
CN1067382A (zh) | 人类乳头状瘤病毒肽的表达以及在致免疫组合物中的应用 | |
CN1216064A (zh) | 合成的hiv基因 | |
CN1291755C (zh) | 增强低免疫原性抗原的免疫原性的药物组合物 | |
CN1194000A (zh) | 增强保护性免疫应答的方法 | |
CN101037475A (zh) | 一种嵌合受体及其制备方法和用途 | |
CN1377279A (zh) | 可溶性共同刺激分子增强免疫应答的用途 | |
CN1960744A (zh) | 肽IL1β和TNFα以及应用其治疗的方法 | |
CN1148448C (zh) | 编码疟疾完全抗原gp190/MSP1的DNA及其制备方法和用途 | |
CN1273191C (zh) | 用于改变b细胞介导病理的方法和组合物 | |
CN1202200A (zh) | Fas配体融合蛋白 | |
CN1668746A (zh) | 具有数目减少的vntr重复单位的muc-1抗原 | |
CN1830489A (zh) | 基于胃泌素释放肽的肿瘤多肽疫苗 | |
CN1948333A (zh) | 一种新的hPEBP4蛋白来源的HLA-A2限制性表位多肽及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20080801 Address after: Shanghai Pudong New Area Jing Road No. 351 Building No. 1 room 431 Applicant after: Shanghai Guojian Biological Technology Institute Address before: Bing Shanghai Road, Pudong New Area Zhangjiang hi tech Park No. 399 Applicant before: Zhongxin Guojian Pharmaceutical Co., Ltd., Shanghai |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: SHANGHAI CP GUOJIAN PHARMACEUTICAL CO.,LTD. Free format text: FORMER OWNER: SHANGHAI GUOJIAN BIOTECHNOLOGY INSTITUTE Effective date: 20110104 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 201203 ROOM 431, BUILDING 1, NO.351, GUOSHOUJING ROAD, PUDONG NEW DISTRICT,SHANGHAI TO: 201203 NO.399, LIBING ROAD, HIGH-TECH PARK, ZHANGJIANG, PUDONG NEW DISTRICT, SHANGHAI |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20110104 Address after: Shanghai city 201203 libing road Pudong New Area Zhangjiang hi tech Park No. 399 Applicant after: Shanghai CP Guojian Pharmaceutical Co., Ltd. Address before: 201203 Shanghai Pudong New Area Jing Road No. 351 Building No. 1 room 431 Applicant before: Shanghai Guojian Biological Technology Institute |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120815 Termination date: 20130315 |